RNF6 and plasma cell myeloma: We also found that RNF6 is highly expressed in hematological malignancies including chronic leukemia (2), acute leukemia (6), and myeloma (1), suggesting that RNF6 auto-ubiquitination and proteasomal degradation are dysregulated or suppressed.